Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS)

Martin Schillinger1, Markus Exner, Wolfgang Mlekusch

  • 1Department of Angiology, of Vienna, Medical School, Vienna, Austria. martin.schillinger@meduniwien.ac.at

Circulation
|April 27, 2005
PubMed

Insights

Inflammation markers, high-sensitivity C-reactive protein (hs-CRP) and serum amyloid A (SAA), are closely linked to the progression of carotid atherosclerosis. Elevated levels indicate active disease and predict worsening atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Medical Diagnostics

Background:

  • Atherosclerosis pathogenesis is strongly linked to inflammation.
  • A clear temporal relationship between inflammation and atherosclerosis progression has been lacking.

Purpose of the Study:

  • To investigate the temporal correlation between inflammatory markers and the progression of carotid atherosclerosis.
  • To assess if baseline and follow-up levels of hs-CRP and SAA predict atherosclerosis progression.

Main Methods:

  • Prospective study of 1268 asymptomatic patients.
  • Serial carotid ultrasound to assess stenosis progression.
  • Measurement of high-sensitivity C-reactive protein (hs-CRP) and serum amyloid A (SAA) at baseline and follow-up.

Main Results:

  • Atherosclerosis progression observed in 8.1% of patients.
  • Both baseline and follow-up hs-CRP and SAA levels, and their changes, were significantly associated with atherosclerosis progression.
  • Increasing quintiles of hs-CRP and SAA were associated with higher odds of atherosclerosis progression.

Conclusions:

  • Findings demonstrate a close temporal correlation between inflammation and morphological features of rapidly progressive carotid atherosclerosis.
  • Elevated hs-CRP and SAA levels identify patients with active atherosclerotic disease.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...